Wearable Devices for Patient Monitoring in Long QT Syndrome
Application of Wearable Devices for Remote QT Interval Monitoring and Symptom Investigation for Patients With Long QT Syndrome
1 other identifier
observational
80
1 country
1
Brief Summary
The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2025
CompletedFirst Posted
Study publicly available on registry
March 20, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2026
ExpectedMay 20, 2025
May 1, 2025
1.1 years
March 14, 2025
May 15, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)
From enrollment to 3 months
2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.
From enrollment to 3 months
Secondary Outcomes (2)
1. Establish the utility of wearable devices for determining symptom aetiology in LQTS.
From enrollment to 3 months
2. Develop pipelines for the analysis of ECG data collected remotely including use of in-house QT automated algorithms for future machine learning applications.
From enrollment to 3 months
Interventions
This is an observational study that does not impact routine clinical care for participants
Eligibility Criteria
Patients with a diagnosis of long QT syndrome
You may qualify if:
- Clinical diagnosis of Long QT Syndrome
- Aged 18 years or over
- Phone with iOS version 15 or Android OS 9.0 or higher
- Able and willing to provide informed consent
You may not qualify if:
- Unwilling or unable to give consent
- Ventricular pacing at recruitment
- Bundle branch block or pre-excitation at baseline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Barts and London Hospital NHS Trust
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William J Young, MBBS, PhD
Queen Mary University of London and St Bartholomew's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2025
First Posted
March 20, 2025
Study Start
April 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
September 4, 2026
Last Updated
May 20, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share